S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen

Clinical trial NCT00602745 · TERMINATED

Trial details

NCT number: NCT00602745
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Neoplasm Neoplasm Metastasis

Start date: 2008-02-01
Primary completion: 2010-03-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.